Flunixin Meglumine 50 mg/g
The active constituent Flunixin is a potent non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic action. Flunixin is rapidly absorbed from the gastrointestinal tract after oral administration (80% bioavailability), with peak plasma levels being reached in approximately 30 - 40 minutes.
Onset of therapeutic effect usually occurs within 2 hours, with peak response within 15 hours and duration of effect up to 30 hours. Flunixin prevents the formation of prostaglandins (PGs) from the precursor arachidonic acid by blocking the action of the enzyme cyclo-oxygenase (prostaglandin synthetase).
For the treatment of inflammation and pain associated with musculoskeletal disorders such as arthritis, laminitis, tendonitis and myositis in horses.
Dosage & Administration
For oral administration.
The recommended dose is 1 g/45 kg bodyweight, equivalent to 1.1 mg/kg bodyweight, once daily for up to five days.
The plunger of the dial-a-dose syringe is calibrated in 2 g (90 kg bwt) increments. Turn the syringe dial to the appropriate mark to deliver the correct dose through the interdental space and onto the back of the tongue.
Each syringe is sufficient to treat one 450 kg horse once daily for three days.
Flunixin Meglumine 50 mg/g paste in 30 g multi-dose syringe.